Format

Send to

Choose Destination
Bone Marrow Transplant. 2019 Jan 10. doi: 10.1038/s41409-018-0423-y. [Epub ahead of print]

Successful treatment of two relapsed/refractory t(8;21) acute myeloid leukemia patients by CD19-directed chimeric antigen receptor T cells.

Qu C1,2,3, Li Z1,2,3, Kang L4,5, Wang Y6, Dai H1,2,3, Yin J1,2,3, Chen G1,2,3, Zhu M1,2,3, Yao L1,2,3, Xu T1,2,3, Tian X1,2,3, Xu Y1,2,3, Chen J1,2,3, Zhu X1,2,3, Yu L4,5, Wu D1,2,3, Tang X7,8,9.

Author information

1
Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, 215000, Suzhou, China.
2
Institute of Blood and Marrow Transplantation, 215000, Suzhou, China.
3
Collaborative Innovation Center of Hematology, Soochow University, 215123, Suzhou, China.
4
College of Chemistry and Molecular Engineering, East China Normal University, 200062, Suzhou, China.
5
Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd, 201203, Suzhou, China.
6
Department of Hematology, The First People's Hospital of Lianyungang, 222061, Suzhou, China.
7
Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, 215000, Suzhou, China. xwtang1020@163.com.
8
Institute of Blood and Marrow Transplantation, 215000, Suzhou, China. xwtang1020@163.com.
9
Collaborative Innovation Center of Hematology, Soochow University, 215123, Suzhou, China. xwtang1020@163.com.
PMID:
30631098
DOI:
10.1038/s41409-018-0423-y

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center